Results per Page:
50 years of doing hard things
Founded in 1975 to honor a brother, Fred Hutch Cancer Center pursued bold science, pioneered a cure for blood diseases that changed medicine and became a world-class biomedical research and clinical care institution
Towards accessible gene therapy: in vivo base editing to cure Sickle Cell Disease
From the Cancer Consortium Lieber Lab, Department of Laboratory Medicine and Pathology, University of Washington
‘If you want to go far, go together’
Fred Hutch scientist Dr. Jennifer Adair partners with colleagues around the globe to make gene therapies more effective and more widely available
How blood cancer research might help organ transplant patients
Fred Hutch study suggests certain immune cells are source of antibodies that attack donated organs
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
Novel transplant approach improves the odds for leukemia patients
Naïve T cells that lead to graft-vs.-host disease removed with magnets
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
Dr. Larry Corey receives public service award from American Society of Gene & Cell Therapy
Sonia Skarlatos Public Service Award recognizes person who has advanced field of gene and cell therapy
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
Hutch research helps launch new genomic medicine company
Ensoma receives $70 million in financing to develop genome modification technologies via a single injection
Tip Sheet: Looking ahead to 2021, COVID-19 vaccines, improving health outcomes — and more
Summaries of recent Fred Hutch research findings and other news
Scientists predict progress against COVID-19, cancer in 2021
After a challenging and deadly 2020, some hopeful predictions for the new year
Advances in blood disorders research continue despite COVID-19
Expanding use of CAR T-cell therapies, gene editing lead to insights at virtual annual meeting of the American Society of Hematology
Timothy Ray Brown, who inspired millions living with HIV, dies of leukemia
For more than a decade after a stem cell transplant, he was the only person known to be cured of HIV/AIDS
Fred Hutch Evergreen Fund awards six grants to promising projects
Scientists receive up to $200K to boost research for projects deemed to have partnership potential
¿La cura del herpes? Hay avances que reportar
Los estudios con ratones muestran que la terapia génica puede reducir muchísimo las infecciones inactivas
$3.5M grant to develop safer treatment for inherited blood disorders
Scientists will study radioactive particles that can precisely deliver a potent punch
Your vote needed! Hutch science competes in 'STAT Madness'
Studies by Drs. Justin Taylor, Robert Bradley are finalists in annual competition for best biomedical advance
The present and future of science intersect in Seattle
Highlights from the annual meeting of the American Association for the Advancement of Science